EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Successful treatment of multidrug-resistant Candida auris ventriculitis with Intraventricular Caspofungin: first report from Türkiye

Melike Nur Özçelik, Melike Demir, Taner Engin, Onur Baran, Ilknur Erdem

The Journal of Infection in Developing Countries · 31.10.2026 · 20 (10) · 1566-1570

DOI: 10.3855/jidc.22209 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.10.2026. Verfasst von Melike Nur Özçelik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tekirdağ Namık Kemal University, Faculty of Medicine, Department of Infectious Diseases, Tekirdağ, Türkiye. Hauptthemen laut MEDLINE: Caspofungin, Antifungal Agents, Cerebral Ventriculitis, Candida auris. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Candida auris is an emerging multidrug-resistant fungus with limited therapeutic options. Central nervous system (CNS) infections are exceptionally rare and difficult to treat due to poor antifungal penetration. Case presentation: This case report presents a 55-year-old woman with hydrocephalus and an external ventricular drain who developed Candida auris ventriculitis on day 48 of her intensive care unit stay. Based on CLSI (Clinical and Laboratory Standards Institute) interpretive criteria, the isolate demonstrated resistance to amphotericin B (MIC 4 µg/mL) and caspofungin (MIC 8 µg/mL), while remaining susceptible to anidulafungin (MIC 0.5 µg/mL).

Results

Intravenous anidulafungin and intraventricular (IVT) caspofungin (10 mg daily) achieved cerebrospinal fluid sterilization within 72 hours, despite the high in-vitro MIC.

Conclusions

This first report from Türkiye demonstrates the potential efficacy of IVT caspofungin in multidrug-resistant Candida auris ventriculitis, emphasizing the importance of pharmacokinetic studies to refine CNS dosing strategies and susceptibility breakpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaspofunginAntifungal AgentsCerebral VentriculitisCandida aurisDrug Resistance, Multiple, FungalCandidiasisEchinocandinsLipopeptidesHumansFemaleMiddle AgedMicrobial Sensitivity TestsTreatment OutcomeAnidulafunginCandidiasis, Invasive

Stichwörter der Autor:innen

Candida aurisexternal ventricular drainventriculitis

Substanzen

CaspofunginAntifungal AgentsEchinocandinsLipopeptidesAnidulafungin

Autor:innen und Institutionen

  • Tekirdağ Namık Kemal University, Faculty of Medicine, Department of Infectious Diseases, Tekirdağ, Türkiye.
  • Tekirdağ Namık Kemal University, Faculty of Medicine, Department of Medical Microbiology, Tekirdağ, Türkiye.
  • Tekirdağ Namık Kemal University, Faculty of Medicine, Department of Neurosurgery, Tekirdağ, Türkiye.
  • Tekirdağ Namık Kemal University, Faculty of Medicine, Department of Anesthesiology and Reanimation, Tekirdağ, Türkiye.

Zitieren

APA

Özçelik, M. N., Demir, M., Engin, T., Baran, O., & Erdem, I. (2026). Successful treatment of multidrug-resistant Candida auris ventriculitis with Intraventricular Caspofungin: first report from Türkiye. The Journal of Infection in Developing Countries, 20(10), 1566-1570. https://doi.org/10.3855/jidc.22209

Vancouver

Özçelik MN, Demir M, Engin T, Baran O, Erdem I. Successful treatment of multidrug-resistant Candida auris ventriculitis with Intraventricular Caspofungin: first report from Türkiye. The Journal of Infection in Developing Countries. 2026;20(10):1566-1570. doi:10.3855/jidc.22209

BibTeX
@article{zelik2026,
  author = {Özçelik, Melike Nur and Demir, Melike and Engin, Taner and Baran, Onur and Erdem, Ilknur},
  title = {Successful treatment of multidrug-resistant Candida auris ventriculitis with Intraventricular Caspofungin: first report from Türkiye},
  journal = {The Journal of Infection in Developing Countries},
  year = {2026},
  volume = {20},
  number = {10},
  pages = {1566--1570},
  doi = {10.3855/jidc.22209}
}
Kostenlos starten →